Symposia

EHRA 2025 - Symposia

Insights from leading experts

Powering the Future of Rhythm Management


Join us at EHRA 2025 for expert-led symposia on the latest advancements in Rhythm Management. Hear from our  experts as they discuss their real-world experiences with various therapeutic approaches.

  

Unfolding Pulsed Field Ablation Developments in Atrial Fibrillation

Unfolding Pulsed Field Ablation Developments in Atrial Fibrillation

March 30, 2025 I 15:00
Room 2 

Moderators
Prof. Sarkozy (BE) and Dr Manninger (AT)

Agenda

PFA Lesion Science and Durability
Dr Rodriguez (ES)

Customizing the Workflow of Pulsed Field Ablation
Prof. Reichlin (CH)

Improving the Precision of Pulsed Field Application
Prof. Szeplaki (IE)

Learning Objectives

  • Learn about PFA clinical science and lesion formation.
  • Showcase an array of the latest clinical evidence for PFA.
  • Discuss PFA workflows in clinical practice and personalized approaches to optimally manage AF patients.
  • Discover latest development of PFA technology workflow and ablation with integrated mapping.
  • Get a glimpse of next generation PFA related developments in mapping, ablation, and access solutions.

 

 

LAAC and AF Ablation are Evolving, Are You?

LAAC and AF Ablation are Evolving, Are You?

March 31, 2025 I 09:45
Room 3 

Moderators
Prof. Boveda (FR) and Prof. Gupta (UK)

Agenda

It’s time to rethink stroke prevention.
Prof. Camm (UK)

The latest clinical evidence.
Dr Melanie Gunawardene (DE)

Mastering innovation in AF: PFA meets LAAC.
Prof. Christian Heeger (DE)

Learning Objectives

  • Examine the evolving landscape of stroke prevention strategies in atrial fibrillation (AF).
  • Analyse the latest clinical trial data, including findings from OPTION and ADVANTAGE AF, and their implications for patient care.
  • Evaluate the impact of emerging technologies, such as left atrial appendage closure (LAAC) and pulsed field ablation (PFA), in optimizing AF management.

 

 

Evolution in Pacing and Risk Management Strategies in Sudden Cardiac Death

Evolution in Pacing and Risk Management Strategies in Sudden Cardiac Death

March 31, 2025 I 14:30
Room 2 

Moderators
Dr Cano (ES) and Dr Chuen (UK)

Agenda

Has the Sudden Cardiac Death Landscape changed? Continuing our patient’s protection mission.
Dr Lüker (DE)

A paradigm shift in Subcutaneous Implantable Cardioverter Defibrillators Therapy: the Modular Approach.
Prof. Lambiase (UK)

The next Frontier in Leadless Cardiac Pacing and Conduction System Pacing.
Prof. Zizek (SL)

Learning Objectives

  • Explore the latest developments in the prevention and management of Sudden Cardiac Death.
  • Emphasize the science of pacing, risk stratification, and innovative approaches in Cardiac device therapy.
  • Integrate clinical evidence and emerging technologies to highlight strategies to personalize treatment and optimize patient outcomes across diverse populations.

 

 

 

CAUTION

The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device. or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries.
This material not intended for use in France.